{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:39Z","timestamp":1783036839029,"version":"3.54.6"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Digestive Chagas disease (DCD) is an enteric neuropathy caused by\n                    <jats:italic>Trypanosoma cruzi<\/jats:italic>\n                    infection. There is a lack of evidence on the mechanism of pathogenesis and rationales for treatment. We used a female C3H\/HeN mouse model that recapitulates key clinical manifestations to study how infection dynamics shape DCD pathology and the impact of treatment with the front-line, anti-parasitic drug benznidazole. Curative treatment 6 weeks post-infection resulted in sustained recovery of gastrointestinal transit function, whereas treatment failure led to infection relapse and gradual return of DCD symptoms. Neuro\/immune gene expression patterns shifted from chronic inflammation to a tissue repair profile after cure, accompanied by increased cellular proliferation, glial cell marker expression and recovery of neuronal density in the myenteric plexus. Delaying treatment until 24 weeks post-infection led to partial reversal of DCD, suggesting the accumulation of permanent tissue damage over the course of chronic infection. Our study shows that murine DCD pathogenesis is sustained by chronic\n                    <jats:italic>T. cruzi<\/jats:italic>\n                    infection and is not an inevitable consequence of acute stage denervation. The risk of irreversible enteric neuromuscular tissue damage and dysfunction developing highlights the importance of prompt diagnosis and treatment. These findings support the concept of treating asymptomatic,\n                    <jats:italic>T. cruzi<\/jats:italic>\n                    -infected individuals with benznidazole to prevent DCD development.\n                  <\/jats:p>","DOI":"10.1038\/s41467-024-48749-5","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T13:02:02Z","timestamp":1716469322000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Enteric nervous system regeneration and functional cure of experimental digestive Chagas disease with trypanocidal chemotherapy"],"prefix":"10.1038","volume":"15","author":[{"given":"Archie A.","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7098-0436","authenticated-orcid":false,"given":"Harry C.","family":"Langston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Roscoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiromani","family":"Jayawardhana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3475-8130","authenticated-orcid":false,"given":"Amanda Fortes","family":"Francisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4147-0693","authenticated-orcid":false,"given":"Martin C.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9324-5984","authenticated-orcid":false,"given":"Conor J.","family":"McCann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4305-5258","authenticated-orcid":false,"given":"John M.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9540-3280","authenticated-orcid":false,"given":"Michael D.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"key":"48749_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.5334\/gh.1150","volume":"17","author":"SA G\u00f3mez-Ochoa","year":"2022","unstructured":"G\u00f3mez-Ochoa, S. A., Rojas, L. Z., Echeverr\u00eda, L. E., Muka, T. & Franco, O. H. Global, regional, and national trends of Chagas disease from 1990 to 2019: comprehensive analysis of the Global Burden of Disease Study. Glob. Heart 17, 59 (2022).","journal-title":"Glob. Heart"},{"key":"48749_CR2","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S1473-3099(13)70002-1","volume":"13","author":"BY Lee","year":"2013","unstructured":"Lee, B. Y., Bacon, K. M., Bottazzi, M. E. & Hotez, P. J. Global economic burden of Chagas disease: a computational simulation model. Lancet Infect. Dis. 13, 342\u2013348 (2013).","journal-title":"Lancet Infect. Dis."},{"key":"48749_CR3","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.3201\/eid2807.212221","volume":"28","author":"A Irish","year":"2022","unstructured":"Irish, A., Whitman, J. D., Clark, E. H., Marcus, R. & Bern, C. Updated estimates and mapping for prevalence of Chagas disease among adults, United States. Emerg. Infect. Dis. 28, 1313\u20131320 (2022).","journal-title":"Emerg. Infect. Dis."},{"key":"48749_CR4","first-page":"25","volume":"13","author":"C Su\u00e1rez","year":"2022","unstructured":"Su\u00e1rez, C., Nolder, D., Garc\u00eda-Mingo, A., Moore, D. A. J. & Chiodini, P. L. Diagnosis and clinical management of Chagas disease: an increasing challenge in non-endemic areas. Res. Rep. Trop. Med. 13, 25\u201340 (2022).","journal-title":"Res. Rep. Trop. Med."},{"key":"48749_CR5","doi-asserted-by":"publisher","first-page":"e1962","DOI":"10.1371\/journal.pntd.0001962","volume":"6","author":"M Navarro","year":"2012","unstructured":"Navarro, M., Navaza, B., Guionnet, A. & L\u00f3pez-V\u00e9lez, R. Chagas disease in Spain: need for further public health measures. PLoS Negl. Trop. Dis. 6, e1962 (2012).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"48749_CR6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","volume":"391","author":"JA P\u00e9rez-Molina","year":"2018","unstructured":"P\u00e9rez-Molina, J. A. & Molina, I. Chagas disease. Lancet 391, 82\u201394 (2018).","journal-title":"Lancet"},{"key":"48749_CR7","doi-asserted-by":"publisher","unstructured":"Berenstein, A. J. et al. Adverse events associated with nifurtimox treatment for Chagas disease in children and adults. Antimicrob. Agents Chemother. https:\/\/doi.org\/10.1128\/aac.01135-20 (2021).","DOI":"10.1128\/aac.01135-20"},{"key":"48749_CR8","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","volume":"373","author":"CA Morillo","year":"2015","unstructured":"Morillo, C. A. et al. Randomized trial of benznidazole for chronic Chagas\u2019 cardiomyopathy. N. Engl. J. Med. 373, 1295\u20131306 (2015).","journal-title":"N. Engl. J. Med."},{"key":"48749_CR9","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S1473-3099(20)30844-6","volume":"21","author":"F Torrico","year":"2021","unstructured":"Torrico, F. et al. New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial. Lancet Infect. Dis. 21, 1129\u20131140 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"48749_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/pim.12786","volume":"43","author":"D P\u00e9rez-Mazliah","year":"2021","unstructured":"P\u00e9rez-Mazliah, D., Ward, A. I. & Lewis, M. D. Host-parasite dynamics in Chagas disease from systemic to hyper-local scales. Parasite Immunol. 43, e12786 (2021).","journal-title":"Parasite Immunol."},{"key":"48749_CR11","doi-asserted-by":"publisher","first-page":"e0008787","DOI":"10.1371\/journal.pntd.0008787","volume":"14","author":"LF Buss","year":"2020","unstructured":"Buss, L. F. et al. Declining antibody levels to Trypanosoma cruzi correlate with polymerase chain reaction positivity and electrocardiographic changes in a retrospective cohort of untreated Brazilian blood donors. PLoS Negl. Trop. Dis. 14, e0008787 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"48749_CR12","unstructured":"Pan American Health Organization. Guidelines for the Diagnosis and Treatment of Chagas Disease (PAHO, Washington, DC, 2019)."},{"key":"48749_CR13","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/01.pas.0000213371.79300.a8","volume":"31","author":"G Iantorno","year":"2007","unstructured":"Iantorno, G. et al. The enteric nervous system in chagasic and idiopathic megacolon. Am. J. Surg. Pathol. 31, 460\u2013468 (2007).","journal-title":"Am. J. Surg. Pathol."},{"key":"48749_CR14","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1590\/S0037-86822004000300012","volume":"37","author":"UG Meneghelli","year":"2004","unstructured":"Meneghelli, U. G. Chagasic enteropathy. Rev. Soc. Bras. Med. Trop. 37, 252\u2013260 (2004).","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"48749_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.gastrohep.2009.07.009","volume":"33","author":"MJ Pinazo","year":"2010","unstructured":"Pinazo, M. J. et al. Diagnosis, management and treatment of chronic Chagas\u2019 gastrointestinal disease in areas where Trypanosoma cruzi infection is not endemic. Gastroenterol. Hepatol. 33, 191\u2013200 (2010).","journal-title":"Gastroenterol. Hepatol."},{"key":"48749_CR16","doi-asserted-by":"publisher","first-page":"e0010796","DOI":"10.1371\/journal.pntd.0010796","volume":"16","author":"AL Bierrenbach","year":"2022","unstructured":"Bierrenbach, A. L. et al. Hospitalizations due to gastrointestinal Chagas disease: National registry. PLoS Negl. Trop. Dis. 16, e0010796 (2022).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"48749_CR17","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/S0002-9440(10)63222-1","volume":"164","author":"RME Arantes","year":"2004","unstructured":"Arantes, R. M. E. et al. Interferon-\u03b3-induced nitric oxide causes intrinsic intestinal denervation in Trypanosoma cruzi-infected mice. Am. J. Pathol. 164, 1361\u20131368 (2004).","journal-title":"Am. J. Pathol."},{"key":"48749_CR18","first-page":"739","volume":"42","author":"F K\u00f6berle","year":"1970","unstructured":"K\u00f6berle, F. The causation and importance of nervous lesions in American trypanosomiasis. Bull. World Health Organ. 42, 739\u2013743 (1970).","journal-title":"Bull. World Health Organ."},{"key":"48749_CR19","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1590\/S0036-46651991000600004","volume":"33","author":"SJ Adad","year":"1991","unstructured":"Adad, S. J., Andrade, D. Cd. S., Lopes, E. R. & Chapadeiro, E. Contribui\u00e7\u00e3o ao estudo da anatomia patol\u00f3gica do megaes\u00f4fago chag\u00e1sico. Rev. Inst. Med. Trop. 33, 443\u2013450 (1991).","journal-title":"Rev. Inst. Med. Trop."},{"key":"48749_CR20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S0140-6736(05)64761-7","volume":"348","author":"AR Vago","year":"1996","unstructured":"Vago, A. R., Macedo, A. M., Adad, S. J., Reis, Dd. \u00c1. & Corr\u00eaa-Oliveira, R. PCR detection of Trypanosoma cruzi DNA in oesophageal tissues of patients with chronic digestive Chagas\u2019 disease. Lancet 348, 891\u2013892 (1996).","journal-title":"Lancet"},{"key":"48749_CR21","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0035-9203(03)90155-6","volume":"97","author":"AR Vago","year":"2003","unstructured":"Vago, A. R., Silva, D. M., Adad, S. J., Correa-Oliveira, R. & d\u2019Avila Reis, D. Chronic Chagas disease: presence of parasite DNA in the oesophagus of patients without megaoesophagus. Trans. R. Soc. Trop. Med. Hyg. 97, 308\u2013309 (2003).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"48749_CR22","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/BF02235488","volume":"44","author":"CE Corbett","year":"2001","unstructured":"Corbett, C. E. et al. Cell-mediated immune response in megacolon from patients with chronic Chagas\u2019 disease. Dis. Colon Rectum 44, 993\u2013998 (2001).","journal-title":"Dis. Colon Rectum"},{"key":"48749_CR23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.4269\/ajtmh.2001.65.435","volume":"65","author":"E Lages-Silva","year":"2001","unstructured":"Lages-Silva, E. et al. Relationship between Trypanosoma cruzi and human chagasic megaesophagus: blood and tissue parasitism. Am. J. Trop. Med. Hyg. 65, 435\u2013441 (2001).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"48749_CR24","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1017\/S0031182005008061","volume":"131","author":"ABM da Silveira","year":"2005","unstructured":"da Silveira, A. B. M. et al. Comparative study of the presence of Trypanosoma cruzi kDNA, inflammation and denervation in chagasic patients with and without megaesophagus. Parasitology 131, 627\u2013634 (2005).","journal-title":"Parasitology"},{"key":"48749_CR25","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.humpath.2007.01.020","volume":"38","author":"ABM da Silveira","year":"2007","unstructured":"da Silveira, A. B. M. et al. Megacolon in Chagas disease: a study of inflammatory cells, enteric nerves, and glial cells. Hum. Pathol. 38, 1256\u20131264 (2007).","journal-title":"Hum. Pathol."},{"key":"48749_CR26","first-page":"232646","volume":"2012","author":"E de Castro C\u00f4bo de","year":"2012","unstructured":"de Castro C\u00f4bo de, E., Silveira, T. P., Micheletti, A. M., Crema, E. & Adad, S. J. Research on Trypanosoma cruzi and analysis of inflammatory infiltrate in esophagus and colon from chronic Chagasic patients with and without mega. J. Trop. Med. 2012, 232646 (2012).","journal-title":"J. Trop. Med."},{"key":"48749_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2022.106632","volume":"235","author":"L Pinto","year":"2022","unstructured":"Pinto, L. et al. Molecular detection and parasite load of Trypanosoma cruzi in digestive tract tissue of Chagas disease patients affected by megacolon. Acta Trop. 235, 106632 (2022).","journal-title":"Acta Trop."},{"key":"48749_CR28","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/cmi.12297","volume":"16","author":"MD Lewis","year":"2014","unstructured":"Lewis, M. D. et al. Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection. Cell. Microbiol. 16, 1285\u20131300 (2014).","journal-title":"Cell. Microbiol."},{"key":"48749_CR29","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1111\/cmi.12584","volume":"18","author":"MD Lewis","year":"2016","unstructured":"Lewis, M. D., Francisco, A. F., Taylor, M. C., Jayawardhana, S. & Kelly, J. M. Host and parasite genetics shape a link between Trypanosoma cruzi infection dynamics and chronic cardiomyopathy. Cell. Microbiol. 18, 1429\u20131443 (2016).","journal-title":"Cell. Microbiol."},{"key":"48749_CR30","doi-asserted-by":"publisher","first-page":"e0195879","DOI":"10.1371\/journal.pone.0195879","volume":"13","author":"E Silberstein","year":"2018","unstructured":"Silberstein, E., Serna, C., Fragoso, S. P., Nagarkatti, R. & Debrabant, A. A novel nanoluciferase-based system to monitor Trypanosoma cruzi infection in mice by bioluminescence imaging. PLoS ONE 13, e0195879 (2018).","journal-title":"PLoS ONE"},{"key":"48749_CR31","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1128\/AAC.00520-15","volume":"59","author":"AF Francisco","year":"2015","unstructured":"Francisco, A. F. et al. The limited ability of posaconazole to cure both acute and chronic Trypanosoma cruzi infections revealed by highly sensitive in vivo imaging. Antimicrob. Agents Chemother. 59, 4653\u20134661 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"48749_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-08086-8","volume":"7","author":"J Santi-Rocca","year":"2017","unstructured":"Santi-Rocca, J. et al. A multi-parametric analysis of Trypanosoma cruzi infection: common pathophysiologic patterns beyond extreme heterogeneity of host responses. Sci. Rep. 7, 1\u201312 (2017).","journal-title":"Sci. Rep."},{"key":"48749_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nature19339","volume":"537","author":"S Khare","year":"2016","unstructured":"Khare, S. et al. Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness. Nature 537, 229\u2013233 (2016).","journal-title":"Nature"},{"key":"48749_CR34","doi-asserted-by":"publisher","first-page":"e0008726","DOI":"10.1371\/journal.pntd.0008726","volume":"14","author":"CM Calvet","year":"2020","unstructured":"Calvet, C. M. et al. Long term follow-up of Trypanosoma cruzi infection and Chagas disease manifestations in mice treated with benznidazole or posaconazole. PLoS Negl. Trop. Dis. 14, e0008726 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"48749_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz2015","volume":"6","author":"E Hossain","year":"2020","unstructured":"Hossain, E. et al. Mapping of host-parasite-microbiome interactions reveals metabolic determinants of tropism and tolerance in Chagas disease. Sci. Adv. 6, eaaz2015 (2020).","journal-title":"Sci. Adv."},{"key":"48749_CR36","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.3389\/fmicb.2019.01856","volume":"10","author":"M Wesley","year":"2019","unstructured":"Wesley, M. et al. Correlation of parasite burden, kDNA integration, autoreactive antibodies, and cytokine pattern in the pathophysiology of Chagas disease. Front. Microbiol. 10, 1856 (2019).","journal-title":"Front. Microbiol."},{"key":"48749_CR37","doi-asserted-by":"publisher","first-page":"e1009864","DOI":"10.1371\/journal.ppat.1009864","volume":"17","author":"AA Khan","year":"2021","unstructured":"Khan, A. A. et al. Local association of Trypanosoma cruzi chronic infection foci and enteric neuropathic lesions at the tissue micro-domain scale. PLoS Pathog. 17, e1009864 (2021).","journal-title":"PLoS Pathog."},{"key":"48749_CR38","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1111\/j.1365-2982.2011.01780.x","volume":"23","author":"LR Rivera","year":"2011","unstructured":"Rivera, L. R., Poole, D. P., Thacker, M. & Furness, J. B. The involvement of nitric oxide synthase neurons in enteric neuropathies. Neurogastroenterol. Motil. 23, 980\u2013988 (2011).","journal-title":"Neurogastroenterol. Motil."},{"key":"48749_CR39","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","volume":"38","author":"Z Yang","year":"2015","unstructured":"Yang, Z. & Wang, K. K. Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci. 38, 364\u2013374 (2015).","journal-title":"Trends Neurosci."},{"key":"48749_CR40","first-page":"Cd003463","volume":"2014","author":"JC Villar","year":"2014","unstructured":"Villar, J. C. et al. Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection. Cochrane Database Syst. Rev. 2014, Cd003463 (2014).","journal-title":"Cochrane Database Syst. Rev."},{"key":"48749_CR41","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrgastro.2014.103","volume":"11","author":"SM Brierley","year":"2014","unstructured":"Brierley, S. M. & Linden, D. R. Neuroplasticity and dysfunction after gastrointestinal inflammation. Nat. Rev. Gastroenterol. Hepatol. 11, 611\u2013627 (2014).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"48749_CR42","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.12454","volume":"5","author":"DG Barrett","year":"2016","unstructured":"Barrett, D. G., Den\u00e8ve, S. & Machens, C. K. Optimal compensation for neuron loss. eLife 5, e12454 (2016).","journal-title":"eLife"},{"key":"48749_CR43","doi-asserted-by":"publisher","first-page":"e01242","DOI":"10.1128\/mBio.01242-20","volume":"11","author":"AI Ward","year":"2020","unstructured":"Ward, A. I. et al. In vivo analysis of Trypanosoma cruzi persistence foci at single-cell resolution. mBio 11, e01242\u201301220 (2020).","journal-title":"mBio"},{"key":"48749_CR44","doi-asserted-by":"crossref","unstructured":"Nogueira, L. G. et al. Myocardial gene expression of T-bet, GATA-3, Ror-t, FoxP3, and hallmark cytokines in chronic Chagas disease cardiomyopathy: an essentially unopposed TH1-type response. Mediat. Inflam. 2014, 914326 (2014).","DOI":"10.1155\/2014\/914326"},{"key":"48749_CR45","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/infdis\/jiw540","volume":"215","author":"LR Ferreira","year":"2017","unstructured":"Ferreira, L. R. et al. Blood gene signatures of Chagas cardiomyopathy with or without ventricular dysfunction. J. Infect. Dis. 215, 387\u2013395 (2017).","journal-title":"J. Infect. Dis."},{"key":"48749_CR46","doi-asserted-by":"publisher","unstructured":"Acevedo, G. R., Girard, M. C. & G\u00f3mez, K. A. The unsolved jigsaw puzzle of the immune response in Chagas disease. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.01929 (2018).","DOI":"10.3389\/fimmu.2018.01929"},{"key":"48749_CR47","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1128\/IAI.01497-15","volume":"84","author":"E Roff\u00ea","year":"2016","unstructured":"Roff\u00ea, E. et al. Trypanosoma cruzi causes paralyzing systemic necrotizing vasculitis driven by pathogen-specific type I immunity in mice. Infect. Immun. 84, 1123\u20131136 (2016).","journal-title":"Infect. Immun."},{"key":"48749_CR48","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/BF01614765","volume":"423","author":"MdL Higuchi","year":"1993","unstructured":"Higuchi, Md. L. et al. Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: Comparison with myocardial rejection process. Virchows Arch. 423, 157\u2013160 (1993).","journal-title":"Virchows Arch."},{"key":"48749_CR49","doi-asserted-by":"publisher","first-page":"E3709","DOI":"10.1073\/pnas.1619406114","volume":"114","author":"S Kulkarni","year":"2017","unstructured":"Kulkarni, S. et al. Adult enteric nervous system in health is maintained by a dynamic balance between neuronal apoptosis and neurogenesis. Proc. Natl Acad. Sci. USA 114, E3709\u2013E3718 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"48749_CR50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jcmgh.2022.04.001","volume":"14","author":"H Virtanen","year":"2022","unstructured":"Virtanen, H., Garton, D. R. & Andressoo, J.-O. Myenteric neurons do not replicate in small intestine under normal physiological conditions in adult mouse. Cell. Mol. Gastroenterol. Hepatol. 14, 27\u201334 (2022).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"48749_CR51","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1097\/MIB.0000000000000326","volume":"21","author":"J Belkind-Gerson","year":"2015","unstructured":"Belkind-Gerson, J. et al. Colitis induces enteric neurogenesis through a 5-HT4\u2013dependent mechanism. Inflamm. Bowel Dis. 21, 870\u2013878 (2015).","journal-title":"Inflamm. Bowel Dis."},{"key":"48749_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-02890-y","volume":"7","author":"J Belkind-Gerson","year":"2017","unstructured":"Belkind-Gerson, J. et al. Colitis promotes neuronal differentiation of Sox2+ and PLP1+ enteric cells. Sci. Rep. 7, 1\u201315 (2017).","journal-title":"Sci. Rep."},{"key":"48749_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-021-01165-z","volume":"9","author":"FA Vicentini","year":"2021","unstructured":"Vicentini, F. A. et al. Intestinal microbiota shapes gut physiology and regulates enteric neurons and glia. Microbiome 9, 1\u201324 (2021).","journal-title":"Microbiome"},{"key":"48749_CR54","doi-asserted-by":"crossref","unstructured":"Laranjeira, C. et al. Glial cells in the mouse enteric nervous system can undergo neurogenesis in response to injury. J Clin. Invest. 121 (2011).","DOI":"10.1172\/JCI58200"},{"key":"48749_CR55","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1172\/JCI58186","volume":"121","author":"NM Joseph","year":"2011","unstructured":"Joseph, N. M. et al. Enteric glia are multipotent in culture but primarily form glia in the adult rodent gut. J. Clin. Invest. 121, 3398\u20133411 (2011).","journal-title":"J. Clin. Invest."},{"key":"48749_CR56","doi-asserted-by":"publisher","first-page":"9879","DOI":"10.1523\/JNEUROSCI.1239-15.2015","volume":"35","author":"T Uesaka","year":"2015","unstructured":"Uesaka, T., Nagashimada, M. & Enomoto, H. Neuronal differentiation in Schwann cell lineage underlies postnatal neurogenesis in the enteric nervous system. J. Neurosci. 35, 9879\u20139888 (2015).","journal-title":"J. Neurosci."},{"key":"48749_CR57","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1002\/glia.24059","volume":"69","author":"T Uesaka","year":"2021","unstructured":"Uesaka, T. et al. Enhanced enteric neurogenesis by Schwann cell precursors in mouse models of Hirschsprung disease. Glia. 69, 2575\u20132590 (2021).","journal-title":"Glia."},{"key":"48749_CR58","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0166-3542(94)90008-6","volume":"25","author":"AM Cheraghali","year":"1994","unstructured":"Cheraghali, A. M., Knaus, E. E. & Wiebe, L. I. Bioavailability and pharmacokinetic parameters for 5-ethyl-2\u2019-deoxyuridine. Antivir. Res. 25, 259\u2013267 (1994).","journal-title":"Antivir. Res."},{"key":"48749_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41492-3","volume":"14","author":"A Laddach","year":"2023","unstructured":"Laddach, A. et al. A branching model of lineage differentiation underpinning the neurogenic potential of enteric glia. Nat. Commun. 14, 5904 (2023).","journal-title":"Nat. Commun."},{"key":"48749_CR60","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/15384101.2015.1006048","volume":"14","author":"P Zhang","year":"2015","unstructured":"Zhang, P., Sun, Y. & Ma, L. ZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance. Cell Cycle 14, 481\u2013487 (2015).","journal-title":"Cell Cycle"},{"key":"48749_CR61","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.12717","volume":"5","author":"S Singh","year":"2016","unstructured":"Singh, S. et al. Zeb1 controls neuron differentiation and germinal zone exit by a mesenchymal-epithelial-like transition. eLife 5, e12717 (2016).","journal-title":"eLife"},{"key":"48749_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109588","volume":"36","author":"B Gupta","year":"2021","unstructured":"Gupta, B. et al. The transcription factor ZEB1 regulates stem cell self-renewal and cell fate in the adult hippocampus. Cell Rep. 36, 109588 (2021).","journal-title":"Cell Rep."},{"key":"48749_CR63","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1523\/JNEUROSCI.4987-09.2010","volume":"30","author":"I Imayoshi","year":"2010","unstructured":"Imayoshi, I., Sakamoto, M., Yamaguchi, M., Mori, K. & Kageyama, R. Essential roles of Notch signaling in maintenance of neural stem cells in developing and adult brains. J. Neurosci. 30, 3489\u20133498 (2010).","journal-title":"J. Neurosci."},{"key":"48749_CR64","doi-asserted-by":"publisher","unstructured":"McCallum, S. et al. Enteric glia as a source of neural progenitors in adult zebrafish. eLife https:\/\/doi.org\/10.7554\/eLife.56086 (2020).","DOI":"10.7554\/eLife.56086"},{"key":"48749_CR65","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1242\/dev.022319","volume":"135","author":"Y Okamura","year":"2008","unstructured":"Okamura, Y. & Saga, Y. Notch signaling is required for the maintenance of enteric neural crest progenitors. Development 135, 3555\u20133565 (2008).","journal-title":"Development"},{"key":"48749_CR66","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"48749_CR67","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 3, 1101 (2008).","journal-title":"Nat. Protoc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-48749-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-48749-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-48749-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T14:07:40Z","timestamp":1716473260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-48749-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["48749"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-48749-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.12.14.520395","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,23]]},"assertion":[{"value":"5 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4400"}}